Ad3-hTERT-E1a, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer

Molecular Therapy - United States
doi 10.1038/mt.2012.115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

112. A Novel Oncolytic Adenovirus Based on Human Adenovirus Serotype 17

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

A Fully Replication-Competent Adenovirus Vector With Enhanced Oncolytic Properties

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2010English

The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus Under a Hypoxic Microenvironment

PLoS ONE
Multidisciplinary
2012English

Therapeutic Efficacy of an hTERT Promoter-Driven Oncolytic Adenovirus That Expresses Apoptin in Gastric Carcinoma

International Journal of Molecular Medicine
MedicineGenetics
2012English

Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon

PLoS ONE
Multidisciplinary
2016English

646. Viral Spread of Adenovirus Serotype 5 Versus Serotype 3 in Epithelial Tumors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Cancer Therapy With a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors

Clinical Cancer Research
Cancer ResearchOncology
2004English

Tamoxifen-Regulated Adenoviral E1A Chimeras for the Control of Tumor Selective Oncolytic Adenovirus Replication in Vitro and in Vivo

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2005English

842. Increased Oncolytic Ability of a Double RGD-Modified Adenovirus in Ovarian Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy